Additionally, Qureshi et al. [44] revealed overexpression of CLPs in the dermis of the nasopharyngeal carcinoma mouse model, and they stated that CLPs are critical therapeutic targets to limit inflammation in cancer. The gene discussed is CLPS; the disease is nasopharyngeal carcinoma.